Isomorphic Labs, an AI drug discovery startup spun out of Alphabet's DeepMind, is in talks to raise new funding valuing the company at $40 billion to $50 billion. This would be a significant increase from its $2.1 billion Series B round five months ago. The startup uses AI to speed up drug discovery, focusing on cancer and immune disorders, and partners with major pharma companies like Eli Lilly and Novartis. The funding talks highlight growing investor interest in AI's role beyond software, particularly in healthcare innovation.
Google's parent company, Alphabet, trades at USD 347.44 on Pluang as of Oct 08, 2026 22:22 WIB, showing a slight 0.02% increase in one day. This stable performance comes while Isomorphic Labs, an Alphabet spin-off, seeks a valuation between $40 billion and $50 billion in a new funding round. The interest in AI-driven healthcare innovation is reflected in Alphabet's significant market cap of $4.27 trillion and active trading volume of over 11 million shares on Pluang. Investors hold Google shares for an average of 137 days, indicating steady confidence in the company's long-term prospects.
Alphabet shares trade 15% below their 52-week high despite faster growth and lower earnings multiples than Microsoft and Meta. The company posted strong Q2 results with 24% revenue growth and 82% growth in Google Cloud, which has a $514 billion backl...
Alphabet is expanding its AI infrastructure ecosystem, including TPUs, Cloud contracts, and strategic investments. Google Cloud generated $24.8 billion in revenue with a 35.6% operating margin, and AI customers use 1.8 times more products. The compan...
Alphabet's stock trades at $340.35, about 15% below its 52-week high, while its cloud backlog has surged to $514 billion, signaling strong future revenue. The company's Q2 revenue rose 24.2%, with Google Cloud growing 82%, yet Alphabet trades at a lo...
Alphabet is highlighted as a strong growth-at-a-reasonable-price (GARP) investment, driven by its new Gemini 4 AI model which is expected to unlock new revenue streams. The company maintains a high return on capital employed (64.7% TTM) and is projec...
A class action lawsuit has been filed against Alphabet Inc. by investors who bought its securities between May 19 and July 16, 2026. The suit alleges that Alphabet misled investors by not disclosing delays and disappointing training results of its AI...
